In a nutshell The authors reviewed the biology as well as current and future treatment options for eye melanoma. Some background Uveal melanoma is a rare cancer (melanoma) of the eye. It involves three parts of the eye (iris, ciliary body and choroid) known together as the uvea. Eye melanoma is associated with a high risk...
Read MoreIn a nutshell The authors aimed to determine the quality-of-life benefits for metastatic melanoma patients treated with dabrafenib compared to dacarbazine. Some background Metastatic melanoma is melanoma that has spread out to other parts of the body from the primary tumor site. Dabrafenib (Tafinlar) and dacarbazine (DTIC) are drugs used to treat...
Read More
In a nutshell This study examined the most accurate predictor of survival in patients with metastatic melanoma being treated with bevacizumab (Avastin). Some background Since melanomas are highly dependent on the formation of new blood vessels, bevacizumab (Avastin), a drug which blocks new blood vessel formation, is often used in their treatment....
Read More
In a nutshell This study investigated the long-term safety and efficacy of ipilimumab in patients with advanced melanoma. Some background Patients with advanced melanoma (cancer of the pigmented cells of the skin, called melanocytes, that has invaded beyond the skin or has spread to the lymph nodes or other organs of the body) often benefit from...
Read More
